The clinical usefulness of assessing the concentration of cell adhesion molecules sVCAM-1 and sICAM-1 in the serum of women with primary breast cancer

Wspolczesna Onkologia

Volumn 18, Issue 4, 2014, Pages 252-259

  Thielemann, Anna ^a   Baszczuk, Aleksandra ^a   Kopczyns̈ki, Zygmunt ^a   Nowak, Adrianna ^a   Grodecka Gazdecka, Sylwia ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

Breast cancer; Cell adhesion molecules; Immunoglobin superfamily; SVCAM 1 and sICAM 1

Indexed keywords

INTERCELLULAR ADHESION MOLECULE 1; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER SIZE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PREMENOPAUSE; PROTEIN BLOOD LEVEL;

EID: 84907209324     PISSN: 14282526     EISSN: None     Source Type: Journal    
DOI: 10.5114/wo.2014.43492     Document Type: Article

References (27)

1. Carmeliet P. Angiogenesis in health and disease. Nat Med 2003; 9: 653-60.
2. Endemann DH, Schiffrin EL. Endothelial dysfunction. J Am Soc Nephrol 2004; 15: 1983-92.
3. Kamezaki S, Kurozawa Y, Iwai N, Hosoda T, Okamoto M, Nose T. Serum levels of soluble ICAM-1 and VCAM-1 predict pre-clinical cancer. Eur J Cancer 2005; 41: 2355-9.
4. Skubitz AP. Adhesion molecules. Cancer Treat Res 2002; 107: 305-29.
5. Pasieka Z. The role of cell adhesion molecules in progression and metastasis process of solid tumors and their usefulness as a neoplasmatic marker in clinical practice. Onkol Pol 2003; 6: 39-44.
6. Alexiou D, Karayiannakis AJ, Syrigos KN, Zbar A, Sekara E, Michail P, Rosenberg T, Diamantis T. Clinical significance of serum levels of E-selectin, intercellular adhesion molecule-1, and vascular cell adhesion molecule-1 in gastric cancer patients. Am J Gastroenterol 2003; 98: 478-85.
7. Perabo F, Sharma S, Gierer R, Wirger A, Fimmers R, Steiner G, Adam M, Schultze-Seemann W. Circulating intercellular adhesion molecule-1 (ICAM-1), vascular cell adhesion molecule-1 (VCAM-1) and E-selectin in urological malignancies. Indian J Cancer 2001; 38: 1-7.
8. Torer N, Kayaselcuk F, Nursal TZ, Yildirim S, Tarim A, Nòyan T, Karakayali H. Adhesion molecules as prognostic markers in pancreatic adenocarcinoma. J Surg Oncol 2007; 96: 419-23.
9. Yasasever V, Tas F, Duranyildiz D, Camlica H, Kurul S, Dalay N. Serum levels of the soluble adhesion molecules in patients with malignant melanoma. Pathol Oncol Res 2000; 6: 42-5.
10. Ahmad A, Hart IR. Mechanism of metastasis. Crit Rev Oncol Hematol 1997; 26: 1021-8.
11. Ilyas M. Adhesion molecule expression in breast cancer: the phoenix in tumour metastasis. J Pathol 2000; 190: 3-5.
12. Gho YS, Kim PN, Li HC, Elkin M, Kleinman HK. Stimulation of tumour growth by human soluble intercellular adhesion molecule-1. Cancer Res 2001; 61: 4253-7.
13. Pietruczuk M, Pietruczuk A, Pancewicz S, Hermanowska-Szpakowicz T. ICAM-1: structure, biological role and clinical significance. Pol Merk Lek 2004; 17: 507-11.
14. Byrne GJ, Ghellal A, Iddon J, Blann AD, Venizelos V, Kumar S, Howell A, Bundred NJ. Serum soluble vascular cell adhesion molecule-1: role as a surrogate marker of angiogenesis. J Natl Cancer Inst 2000; 92: 1329-36.
15. Fox SB, Turner GD, Gatter KC, Harris AL. The increased expression of adhesion molecules ICAM-3, E- and P- selectins on breast cancer endothelium. J Pathol 1995; 177: 369-76.
16. Guerrero-Esteo M, Ruiz-Velasco N, Muñoz M, Teixidó J. Role of two conserved glycine residues in the beta-propeller domain of the integrin alpha4 subunit in VLA-4 conformation and function. FEBS Lett 1998; 5: 123-8.
17. Sheen-Chen SM, Eng HL, Sheen CW, Cheng YF, Chou FF, Chen WJ. Serum levels of circulating intercellular adhesion molecule-1 in patients with breast cancer. Anticancer Res 1997; 17: 2823-6.
18. Madej B. Analysis of selected neoplastic factors in breast cancer in reference to formation of distant metastases. Lublin University of Medical Sciences, Poland 2005.
19. O'Hanlon DM, Fitzsimons H, Lynch J, Tormey S, Malone C, Given HF. Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma. Eur J Cancer 2002; 38: 2252-7.
20. Sun JJ, Zhou XD, Liu YK, Tang ZY, Feng JX, Zhou G, Xue Q, Chen J. Invasion and metastasis of liver cancer: expression of intercellular adhesion molecule 1. J Cancer Res Clin Oncol 1999; 125: 28-34.
21. De Vita F, Infusino S, Auriemma A, Orditura M, Catalano G. Circulating levels of soluble intercellular adhesion molecule-1 in nonsmall cell lung cancer patients. Oncol Rep 1998; 5: 393-6.
22. Ke JJ, Shao QS, Ling ZQ. Expression of E-selectin, integrin beta 1 and immunoglobulin superfamily member in human gastric carcinoma cells and its clinicopathologic significance. World J Gastroenterol 2006; 12: 3609-11.
23. Ding YB, Chen GY, Xia JG, Zang XW, Yang HY, Yang L. Association of VCAM-1 overexpression with oncogenesis, tumor angiogenesis and metastasis of gastric carcinoma. World J Gastroenterol 2003; 9: 1409-14.
24. Czekierdowski A, Czekierdowska S. The assessment of angiogenic factors VEGF, VEGFR-2 and VCAM-1 in the serum of women with malignant ovarian tumours bevore and after the menopause. Prz Menopauz 2007; 3: 128-33.
25. Olszewski WT. Pathological prognostic factors in breast cancer. New Med 2002; 119: 2-5.
26. Hyun KK, Kyoung RL, Eun SL. Circulating vascular cell adhesion molecule-1 in patients with operable breast cancer. J Thromb Haemostasis 2003; 1: 12-8.
27. Yoo NC, Chung HC, Chung HC, et al. Synchronous elevation of soluble intercellular adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule 1 (VCAM-1) correlates with gastric cancer progression. Yonsei Med J 1998; 39: 27-36.